Receptor protein-tyrosine phosphatase a (RP'I'Pcz) is a transmembrane member of the family of protein-tyrosine phosphatases (PTPs) that has been implicated in neuronal differentiation in vitro. Here we demonstrate that RPTPa is differentially expressed during mouse embryogenesis in a spatio-temporal manner. RPTPa expression was detectable in 6 days post coitum (dpc) embryos, but not in 7.5 dpc embryos. From 10.5 dpc onwards a striking RPTPa expression pattern was observed with elevated levels in the dorsal root ganglia, cranial ganglia and adrenal gland, suggesting that RF'TPa levels are specifically enhanced in neural crest derivatives. Marked differences between RPTF'a mRNA and protein levels indicated that RFTPa expression is regulated by transcriptional and (post-) translational mechanisms. The expression pattern of RPTPa suggests that RPTPa may play a role in neural crest cell differentiation in vivo.
Introduction
Tyrosine phosphorylation, one of the main eukaryotic cell signalling mechanisms, is regulated by the antagoiiistic activities of protein-tyrosine kinases (PTKs) and protein-tyrosine phosphatases (PTPs) (Schlessinger and Ullrich, 1992; Hunter, 1995) . Much emphasis has been placed in recent years on elucidation of the function of PTKs, which has led to the insight that PTKs play a pivotal role in development. In this respect, relatively little is known about the PTPs. More than 40 PTPs, both cytoplasmic and transmembrane, have been cloned. All PTPs contain one or two homologous catalytic domains of approximately 250 amino acids (Fischer et al., 1991; Charbonneau and Tonks, 1993; . The transmembrane PTPs are tentatively called receptor PTPs (RPTPs), since they have the potential to transduce signals across the membrane due to their topology. Part of the extracellular domain of RPTPj?, the carbonic anhydrase domain, is a functional ligand for contactin, inducing neurite outgrowth of tectal neurons and differentiation * Corresponding author. Tel.: +31 30 2510211; fax: +31 30 2516464; e-mail: hertog@hubrecht.nl of neuroblastoma cells (Peles et al., 1995) . In addition, the extracellular domains of RPTPp and RPTPK engage in homophilic interactions when expressed at high levels on apposing cells (Brady-Kalnay et al., 1993; Gebbink et al., 1993; Sap et al., 1994) . However, wlie*er interactions of the extracellular domains affect intracellular PTP activity remains to be determined.
Analysis of the expression patterns of a number of PTPs has led to speculations about a possible role of PTPs in neural development. Three Drosophila receptor PTPs are expressed on a subset of neuronal cells, suggesting a role for these PTPs in axon guidance and neuronal outgrowth (Tian et al., 1991; Yang et al., 1991) . The receptor PTPs DLAR DPTP69D and DPTP99D have now been shown to control motor axon guidance in the Drosophila embryo using loss-of-function mutants (Desai et al., 1996; Krueger et al., 1996) . In mammals, many PTPs are highly expressed in the brain during embryogenesis (Barnea et al., 1993; Sahin et al., 1995; Shock et al., 1995) and CPTPl appears to be expressed preferentially in the developing rat central nervous system (Sahin et al., 1995) . Furthermore, expression of several PTPs is induced during neuronal differentiation of cells growing in vitro (den Hertog et al., 1993; Sharama and Lombroso, 1995; Zhang and Longo, 1995) . Although the in vivo expression patterns and the inducibility in vitro suggest an important role for PTPs in neurogenesis in vivo and in vitro, the actual involvement of most PTPs in neural development remains to be determined.
Receptor protein-tyrosine phosphatase a (RPTPa) is a transmembrane PTP with a relatively short extracellular domain and, like most transmembrane PTPs, a tandem repeat of two homologous cytoplasmic PTP domains (Matthews et al., 1990; Sap et al., 1990) . The N-terminal PTP domain contains the majority of the activity, while the C-terminal PTP domain exhibits detectable, but low PTP activity towards exogenous P.Tyr-containing substrates (Wang and Pallen, 1991; den Hertog et al., 1994) . The function of RPTPa remains largely obscure. The cytoplasmic PTK c&c and the insulin receptor have been identified as candidate substrates (Zheng et al., 1992; den Hertog et al., 1993; Mller et al., 1995) , but whether these PTKs are physiological substrates of RPTPa remains to be determined definitively.
RPTPa activity is regulated by phosphorylation, since serine phosphorylation of two residues in the juxtamembrane region enhances RPTPa activity directly (den Hertog et al., 1995; Tracy et al., 1995) . Phosphorylation of RPTPa Tyr789, close to the Cterminus, provides a binding site for the SH2 domain of the SH3-SH2-SH3 adaptor protein GRB2 (den Hertog et al., 1994; Su et al., 1994) . Binding of GRB2 may inhibit RPTPa activity, since the C-terminal SH3 domain interacts with a region close to the catalytic site cleft in the Nterminal PTP domain of RPTPa, thereby conceivably blocking access to the catalytic site (den Hertog and Hunter, 1996) .
RPTPa may play an important role in neuronal differentiation, since RPTPa mRNA levels are enhanced during neuronal differentiation of three distinct cell lines in vitro (den Hertog et al., 1993) . In addition, overexpression of RPTPa in pluripotent murine P19 embryonal carcinoma cells leads to a dramatic change in differentiation fate in favor of neuronal differentiation.
Whereas retinoic acidtreatment induces wild type PI9 embryonal carcinoma cells to differentiate into derivatives of endoderm and mesoderm, RPTPa-expressing P19 cells differentiate into neuronal cells under similar conditions, as illustrated, for example, by their capacity to generate action potentials (den Hertog et al., 1993) . PTP activity of the N-terminal PTP domain of RPTPa is essential for this function of RPTPa (den Hertog et al., 1993) , but the interaction with GRB2 is not (den Hertog and Hunter, 1996) . Apparently, RPTPa plays a decisive role in the selection of the neuronal pathway of P19 embryonal carcinoma cells.
Since RPTPa appears to be involved in neurogenesis of cells growing in vitro, we were interested to study the potential developmental role of RPTPa in further detail. So far, such an analysis had been limited to the observation that RPTPa mRNA is ubiquitously expressed at low levels in 17 day old rat embryos with elevated expression in the neural tube and cortex (Sahin et al., 1995) . We now report on the expression pattern of RPTPa mRNA and protein during mouse embryogenesis from 6 days post coitum (dpc) onwards. RPTPa mRNA expression was detectable from 6 dpc onwards, and its expression was dramatically enhanced in the dorsal root ganglia, cranial ganglia, adrenal gland and cortex of older embryos, indicating that RPTPa expression is transcriptionally regulated in a spatio-temporal manner. RPTPa protein was detectable in 6 dpc embryos, but not in 7.5 dpc embryos. From 10.5 dpc onwards a striking RPTPa protein expression pattern was observed with elevated levels in the dorsal root ganglia, cranial ganglia and adrenal gland, suggesting that RPTPa levels are specifically enhanced in derivatives of the neural crest. Marked differences were observed between RPTPa mRNA and protein expression, indicating that RPTPa expression is regulated not only by transcription, but also by (post-)translational mechanisms. Elevated expression of RPTPa in post-migratory derivatives of the neural crest suggests that RPTPa may play a role in neural crest cell differentiation in vivo.
Results

Spatio-temporal expression of RPTPa mRNA during mouse embryogenesis
Expression of RPTPa during mouse embryogenesis was initially studied by in situ hybridization. Several probes derived from the unique extracellular, transmembrane and juxtamembrane region of RPTPa were tested by in situ hybridization using sections of 15.5 dpc embryos. A 328 bp PstL-EcoRI fragment encoding the transmembrane region and part of the juxtamembrane region was selected, because RPTPa was readily detectable using this antisense probe, and no signal was detected using the control sense probe. Sequence comparison indicated that this 328 bp region is highly unique for RPTPa. For instance, this region in RPTPa shows only 37% identity with the corresponding region in its most closely related PTP, RPTPs (Elson and Leder, 1995) .
In situ hybridization was done using parasagittal sections of post-implantation mouse embryos, ranging in age from 6 to 15.5 dpc. Very low RPTPa mRNA levels were detected throughout the 6 dpc embryo proper ( Fig. 1 A-D) , and the 7.5 dpc embryo proper ( Fig. lE-H) . The extra-embryonic region of the egg cylinder also showed low, but detectable RPTPa mRNA expression (Fig.  lC,D) . High expression was detected in the trophoectoderm immediately surrounding the 6 and 7.5 dpc embryos. Furthermore, the decidua around the 6 and 7.5 dpc embryos expressed very high RPTPa mRNA levels ( Fig.   1 ).
Whereas RPTPa mRNA was evenly distributed throughout 6 and 7.5 dpc embryos, RPTPa mRNA ex- Fig. 1 . RPTPa mRNA expression in b'dpc and 7.5 dpc mouse embryos. In situ hybridization using an RPTPa-specific probe and sagittal sections of 6 dpc (A-D) and 7.5 dpc (B-H) mouse embryos was done as described in Section 4. Bright field (A,C,E,G) and corresponding dark field (B,D,F,H) pictures are. shown. Abbreviations: al, allantois; eep, extra-embryonic part; ep, embryonic part; te, trophoectoderm. Bars represent 50Oym (A,E) and 100pm (C,G). pression was specifically enhanced in certain tissues of older embryos (Fig. 2) . In 9.5 dpc embryos slightly elevated RPTPa mRNA levels were detected in the neural tube, the forebrain and the hindbrain ( Fig. 2A) . RPTPa mRNA expression was clearly enhanced in the dorsal root ganglia and cranial ganglia, notably the inferior vagal ganglion, of 11.5 dpc embryos (Fig. 2C ). In addition, slightly elevated levels of RPTPa mRNA expression were detectable in the forebrain, midbrain and hindbrain regions of 10.5 and 11.5 dpc embryos. Clearly localized enhanced expression was apparent in 13.5 dpc mouse embryos ( Fig. 2D-F) . The dorsal root ganglia, cranial ganglia, including the vestibulocochlear ganglion, and adrenal gland (not present in this section) showed highest expression, while intermediate expression was detected in the neopallial cortex. The rest of the embryo, including the internal organs heart, liver, lung and kidney, stained weakly positive, as illustrated by comparison of the signal with an adjacent section hybridized with the control sense probe (cf. Fig. 2E ,F). Similar control hybridizations were done for all sections depicted here. No specific signal was detected in any section using the control sense probe (data not shown). RPTPa mRNA expression was detectable throughout 15.5 dpc embryos with elevated levels of expression in the cortex. High expression was detected in the adrenal gland, dorsal root ganglia and cranial ganglia, including the trigeminal ganglion and inferior vagal ganglion ( Fig. 2G,H) . RPTPa mRNA expression detected in 10.5-15.5 dpc mouse embryos is summarized in Table  1 . Taken together, RPTPa mRNA is detectable from 6 dpc onwards and in older embryos RPTPa mRNA expression is enhanced in the adrenal gland, cortex, dorsal ganglia and cranial ganglia, indicating that RPTPa mRNA is differentially expressed in a spatio-temporal manner during mouse embryogenesis.
RPTPa protein expression during early postimplantation development
RPTPa protein expression was studied by immunohistochemistry using anti-RPTPa antibodies as described in Section 4. Anti-RPTPa antibodies were raised against a bacterially expressed glutathione-S-transferase fusion protein encompassing the complete cytoplasmic region of RPTPa (den Hertog et al., 1994) . Following affinitypurification, the antibody is highly specific for RPTPa, as illustrated by immunoblotting using whole cell lysates of NIH 3T3 cells (data not shown). As a control for the immunohistochemistry experiments, the antibody was depleted from the solution by incubation with antigen coupled to glutathione-agarose beads, and the depleted antibody solution was used exactly as the antibody solution. Fig. 3 shows staining for RPTPa protein using 6 and 7.5 dpc embryos. Comparison of the samples incubated with anti-RPTPa antibodies and control solutions indicated that the 6 dpc embryo proper (cf. Fig. 3B,D) , but not the 7.5 dpc embryo proper (cf. Fig. 3F .H) expressed low but detectable
RPTPa protein levels. The extraembryonic region of the 6 dpc egg cylinder showed high RPTPa protein expression (Fig. 3B) , while RPTPa protein was not detectable in the extra-embryonic part of 7.5 dpc embryos (Fig. 3F) . The trophoectoderm surrounding the 6 dpc and 7.5 dpc embryos as well as the decidua stained highly positive for RPTPa protein (Fig. 3A,E) . High RPTPa protein levels in the decidua surrounding 6 and 7.5 dpc embryos were consistent with high RPTPa mRNA expression (Fig. 1) . By contrast, high protein levels were detected in the extra-embryonic part of the 6 dpc egg cylinder, while RPTPa mRNA expression in that region was very low. These results demonstrate that RPTPa protein is expressed in 6 dpc embryos, but not in 7.5 dpc embryos, and indicates that RPTPa protein expression is regulated during early post-implantation development.
Enhanced RPTPa expression in neural crest derivatives
Since photographic reproduction of immunohistochemically stained older embryos (from 9.5 dpc onwards) was impossible, only higher magnifications are shown here (see below). RPTPa protein was readily detectable throughout 9.5 dpc embryos (data not shown), consistent with RPTPa mRNA expression in those embryos ( Fig.  2A) . Expression of RPTPa protein in 10.5-15.5 dpc embryos is summarized in Table 2 . RPTPa protein was hardly detectable in the internal organs liver, lung and kidney. By contrast, the heart showed enhanced RPTPa protein expression, especially in younger (10.5 dpc) embryos (Table 2) . Dorsal root ganglia can be recognized as separate structures from 10.5 dpc onwards. A slight increase in RPTPa mRNA was detected in dorsal root ganglia of 10.5 dpc embryos, while RPTPa mRNA expression was markedly enhanced in the dorsal root ganglia of older RPTPa mRNA expression was determined by in situ hybridization using an RPTPa-specific 35 S-labelled probe as described in Section 4 using 10.5, 11.5, 13.5 and 15.5 dpc embryos as indicated. +I-, +, ++ and +++ indicate relative levels of expression; (a) indicates tissue not or partially developed. embryos (Fig. 2) . Higher magnification of the in situ hybridizations depicted in Fig. 2 show that enhanced RPTPa mRNA expression in the dorsal root ganglia appeared to be distributed evenly (Fig. 4) . Analysis of a large number of sections from different embryos indicated that there were no significant differences in RPTPa mRNA expression between the anterior and posterior dorsal root ganglia. RPTPa protein expression was detectable in the dorsal root ganglia of 10.5 dpc embryos (cf. Fig. 5A,B) . Intense staining of the dorsal root ganglia was observed in 11.5 dpc embryos (Fig. 5C ). The intensity of staining of the dorsal root ganglia gradually decreased in 13.5 and 15.5 dpc embryos, but RPTPa expression was still elevated as compared to the surrounding tissue (Fig. 5E,G) . Higher magnification of the dorsal root ganglia clearly showed weak staining in 10.5 dpc embryos (Fig. 6A) . Almost all cells in the dorsal root ganglia of 11.5 dpc embryos stained positive (Fig. 6B) , while not all cells in the dorsal root ganglia of 13.5 and 15.5 dpc embryos expressed RPTPa protein (Fig. 6C,D) . Some cells stained intensely positive, while adjacent cells hardly showed RPTPa expression. At all stages weakly RPTPa-positive neurites were observed extending out of the dorsal root ganglia, as indicated in Fig. 6D . These observations indicate that RPTPa protein is expressed in dorsal root ganglia from the onset of their formation onwards.
The in situ hybridizations showed enhanced expression of RPTPa in the adrenal primordium and adrenal gland of 13.5 and 15.5 dpc embryos, respectively (Fig. 2) . The signal is elevated throughout the adrenal gland and its precursor compared to the surrounding tissue (Fig. 7B,E) . Intense staining of the adrenal primordium and adrenal Fig. 2 . Expression of RPTPa mRNA in mouse embryos ranging from 9.5 to 15.5 dpc. RPTPa mRNA expression was determined by in situ hybridization as in Section 4 using an RPTPa-specific probe, except in (F), where the control (sense) probe was used. Sagittal sections of 9.5 dpc (A), 10.5 dpc (B), 11.5 dpc (C), 13.5 dpc (D-F) and 15.5 dpc (G,H) embryos were used. Dark field (A-C,E,F,H) and bright field (D,G) pictures are shown. Abbreviations: ag, adrenal gland; drg, dorsal root ganglion; fv, fourth ventricle; he, heart; hp. hepatic primordium; ig, inferior ganglion; ivg, inferior vagat ganglion; ki, kidney; Ii, liver; lu, lung; mn, metanephros; mv, mesencephalic vesicle; nc, neopallial cortex; nt, neural tube; st, stomach; tg, trigeminal ganglion; tv, telencephahc vesicle; vcg, vestibulocochlear ganglion; vg, vagal ganglion. Bars represent 5OOym (A-C) and 1 mm (D,G).
qf Development 58 (1996) 89-101 Fig. 3 . RPTPa protein expression in 6 and 7.5 dpc embryos. Immunohistochemistry was done using sag&al sections of 6 dpc (A-D) and 7.5 dpc (E-H) embryos and anti-RPTPa-specific antibodies (A,B,E,F) or a control antibody-depleted solution (C,D,G,H) as described in Section 4. The sections were developed using avidin/biotinylated horse radish peroxidase enhancement with DAB as a substrate. Abbreviations: al, allantois; de, decidua; eep, extra-embryonic part; ep, embryonic part; te, trophoectoderm.
Bars represent 500pm (A,C,E,G) and 1OOpm (B,D,F,H).
gland was detected by immunobistochemistry, indicating that RPTPa protein is highly expressed (Fig. 7C,F) . Highest levels of RPTPa protein expression were found close to the adrenal cortex in cells morphologically resembling medullary cells. It is noteworthy that the dorsal root ganglia as well as the medullary cells of the adrenal gland are derivatives of neural crest, suggesting that RPTPa expression is specifically enhanced in neural crest derivatives.
Since cranial sensory ganglia are also derived from neural crest, expression of RPTPa in the head was investigated in more detail using transverse sections of 15.5 dpc embryos. As depicted in Fig. 8 , expression of RPTPa mRNA and protein was elevated in cranial ganglia, including the trigeminal ganglia and glossopharyngeal ganglia. In addition, RPTPa mRNA and protein expression was readily detectable in the dorsal root ganglia and infundibulum of the pituitary (Fig. 8C,D,G,H) . Similar to the punctate expression pattern in dorsal root ganglia (Figs. 5 and 6), RPTPa protein was not evenly distributed in the cranial ganglia, in that some cells showed intense staining, whi.le adjacent cells hardly stained positive (Fig. 8C,D) . In conclusion, these results demonstrate that RPTPa expression is specifically enhanced in derivatives of the neural crest, including dorsal root ganglia, cranial sensory ganglia and the medullary cells of the adrenal gland. RPTPa protein expression was determined by immunohistochemistry using affinity purified polyclonal anti-RPTPa antibody 5478 as described in Section 4 using sections of 10.5, 11.5, 13.5 and 15.5 dpc embryos as indicated. +/-, +, ++ and +++ indicate relative intensities of staining; (a) indicates tissue not or partially developed. 
(Post-)translational regulation of RPTPa expression
RPTPa mRNA and protein expression levels are similar in some tissues. For instance, high expression was observed in the dorsal root ganglia by in situ hybridization and by immunohistochemistry.
The neural tube showed low protein expression, consistent with very low RPTPa mRNA levels. However, RPTPa mRNA and protein expression differed in some other tissues, as indicated in Table 3 . Although relatively high mRNA levels were detected in the neopallial cortex and choroid plexus compared to surrounding tissue, for instance the diencephalon, RPTPa protein was hardly detectable (Fig. 9) . By contrast, RPTPa protein was readily detectable in certain muscles in the head, while RPTPa mRNA levels were not elevated compared to the surrounding tissue (cf. Fig. 8D,H) . These results indicate that RPTPa expression is not only regulated by transcription, but also by translational and/or post-translational mechanisms.
Discussion
Whereas it has been established that PTKs play an important role in development, relatively little is known in this respect about the enzymatic counterpart of the PTKs, the PTPs. Previously, we have provided evidence that the transmembrane PTP RPTPa is involved in neuronal differentiation in vitro (den Hertog et al., 1993) , but the function of RPTPa in vivo remains to be elucidated. In order to begin to understand the role of RPTPa in development, we studied RPTPa mRNA and protein, expression during mouse embryogenesis.
Here we report that RPTPa expression is regulated in a spatio-temporal manner during embryogenesis.
RPTPa levels were low, but detectable in early post-implantation embryos and RPTPa expression was specifically enhanced in derivatives of the neural crest in older embryos.
Northern blotting analysis indicated that RPTPa mRNA is ubiquitously expressed in adult mice, and that expression is elevated in kidney, brain and liver (Sap et al., 1990) . In the adult rat, RPTPa expression was most prominent in the brain, while elevated expression was detected in kidney, lung and heart. In addition, RPTPa mRNA was detected throughout 17 day old rat embryos with highest levels of expression in the cortex and neural tube (Sahin et al., 1995) . Here, we demonstrate that RPTPa mRNA expression is dramatically enhanced in the adrenal gland, dorsal root ganglia and cranial ganglia of of Development 58 (1996) [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] . RPTPa mRNA and protein expression is enhanced in the adrenal gland. In situ hybridization (A,B,D,E) and immunohistochemistry (C,I :) of sagi ttal sections of 13.5 dpc (A-C) and 15.5 dpc (D-F) embryos using an RPTPa-specific 35S-labelled probe and anti-RPTPa antibodies, respecti! rely. Abb reviations: ag, adrenal gland; ap, adrenal primordium; drg, dorsal root ganglion; ki, kidney; mn, metanephros. Bars represent 300pm (A,D) and 150 pm (C,F). older embryos. By contrast to the expression pattern in rat embryos, only moderately elevated RPTPa mRNA levels were observed in the cortex and the neural tube showed slightly enhanced RPTPa mRNA levels. It is possible, however unlikely, that the regulation of RPTPa mRNA expression is different in mouse and rat. The probe that we used for the in situ hybridizations was derived from the transmembrane and juxtamembrane region in RPTPa that is highly unique. The sequence identity between RPTPa and its most closely related PTP, RPTPE, in this region is only 37%. The probe that was used by Sahin et al. (1995) was derived from a region in the N-terminal PTP domain that is homologous to RPTPs (69% sequence identity). Therefore, it is possible that cross-hybridization of the RPTPa probe with RPTP.s or other related PTPs accounts for the observed high expression in the rat neural tube, and thus for the discrepancy in expression between rat and mouse. Low levels of RPTPa mRNA expression were detected throughout embryogenesis. Ubiquitous expression of RPTPa throughout the embryo is consistent with the finding that the genomic sequence upstream of the RPTPa transcription initiation site contains characteristics of promoters of widely expressed genes, including multiple GC boxes and a 'CpG' island (Wong et al., 1993) . Whether this upstream region actually is a functional promoter remains to be determined. This putative RPTPa promoter region cannot explain the observed elevated RPTPa expression in dorsal root ganglia and cranial ganglia. However, the RPTPa cDNA'that we have cloned (den Hertog et al., 1992) contains 5' non-translated sequences that are distinct from the published sequence. In fact, the exon l-exon 2 boundary coincides exactly with the difference in sequence, in that exon 1 is entirely different from the published sequence and exon 2 is identical. This suggests that the cDNA we have cloned may originate from a distinct promoter. Currently, we are investigating the possibility that RPTPa expression is driven by multiple promoters.
In early post-implantation embryos RPTPa mRNA is expressed at low levels (Fig. 1) . By contrast, RPTPa protein is highly expressed in the extra-embryonic part of the 6 dpc egg cylinder, while in the embryo proper RPTPa protein levels are low but detectable (Fig. 3) . The fact that RPTPa protein is not detectable in 7.5 dpc embryos indicates that RPTPa protein expression is transient in early post-implantation embryos.
The difference between RPTPa mRNA and protein expression in 6 dpc embryos can be explained by the fact that mRNA expression precedes protein expression. The mRNA could be almost completely degraded in 6 dpc embryos, while FtPTPa protein is still present. At this time we cannot exclude the possibility that maternal mRNA transcripts account for the observed RPTPa protein expression in 6 dpc embryos. High expression of RPTPa in the decidua surrounding the 6 dpc embryos and transient expression of RPTPa protein in early post-implantation embryos may suggest that RPTPa plays a role in the implantation process.
In older embryos, RPTPa mRNA and protein is highly expressed in medullary cells of the adrenal gland, dorsal root ganglia and cranial sensory ganglia. These structures are all derived from the neural crest. Apparently, neural crest derivatives express enhanced levels of RPTPa following migration, since elevated RPTPa expression was detected as soon as, for instance, the dorsal root ganglia could be recognized as separate structures, but not before. RPTPa protein expression in dorsal root ganglia is transient with maximal levels of expression in 11.5 dpc embryos. While all cells stain positive for RPTPa expression in dorsal root ganglia of 11.5 dpc embryos, a punctate expression pattern was observed in dorsal root ganglia of 13.5 and 15.5 dpc embryos. Some cells showed intense staining, while adjacent cells expressed very low levels of RPTPa protein (Fig. 6 ). An explanation for the observed punctate expression pattern in ganglia may be that RPTPa expression is linked to the differentiation state of these cells. Terminal differentiation of neural crest cells occurs following migration and the differentiation fate appears to depend in part on the final location. Previously, we have demonstrated that RPTPa plays a decisive role in the selection of the terminal neuronal differentiation pathway of PI9 embryonal carcinoma cells growing in vitro (den Hertog et al., 1993) . The expression pattern of RPTPa during embryogenesis suggests that RPTPa may play a similar role in post-migratory neural crest cell differentiation in vivo.
Comparison of relative RPTPa mRNA and protein expression indicates that there are differences (Table 3) . In older embryos, RPTPa protein was readily detectable in muscle, while RPTPa mRNA was not enhanced compared to the surrounding tissue. The converse situation was observed in the cortex; RPTPa mRNA was readily detectable, but only very low levels of RPTPa protein were detectable. These results suggest that RPTPa protein expression is not only regulated by transcription, but also by translation and possibly by post-translational processes. For instance, the half-life of RPTPa protein in muscle may be much greater than in the cortex, resulting in a lack of apparent protein expression in the cortex and high RPTPa protein levels in muscle. It has been established that receptor PTKs are internalized and degraded upon ligand binding (Schlessinger and Ullrich, 1992) . Although ligands have not been identified for RPTPa, a similar mechanism may account for the apparent absence of RPTPa protein in the cortex, in that RPTPa, complexed with its ligand, may continuously be internalized and degraded. This hypothesis would predict that the putative RPTPa ligand is present in the cortex, but not in muscle.
The molecular mechanism underlying RPTPa function has not yet been elucidated. In fact, little is known about the biological function of any PTP. To understand the function of PTPs, it is imperative to identify specific, drg, dorsal root ganglion; gg, glossopharyngeal ganglion; ip, infundibulum of the pituitary; mu, muscle, nc, neopallial cortex; nt, neural tube; tg, trigemihal ganglion. Bars represent 1 mm (A,B) and SOO~m (CD). Fig. 9 . Expression of RPTPa mRNA, but not protein in the cortex. Immunohistochemistry using RPTPa antibodies (A) and in situ hybridization using an RPTPa-specific probe (B) or a control (sense) probe (C) were done as described in the experimental procedures using adjacent sagittal sections. Abbreviations:
cp, choroid plexus; de, diencephalon; Iv, lateral ventricle; nc, neopallial cortex. Bar represents 4OO~m. physiological substrates. To date, specific substrates of only a few PTPs are known. We and others identified the PTK c-Src as a possible substrate of RPTPa, since overexpression of RPTPa in rat embryo fibroblasts and P19 embryonal carcinoma cells led to dephosphorylation of the inhibitory C-terminal phosphotyrosine residue in cSrc, and thus to activation of c-Src (Zheng et al., 1992; den Hertog et al., 1993) . Recently, it was demonstrated that insulin receptor signalling was specifically downregulated by overexpression of RPTPa and RPTPa (Moller et al., 1995) . It is possible that RPTPa plays a dual role in vivo, in that RPTPa activates c-Src on the one hand and attenuates insulin receptor signalling on the other. It is tempting to speculate that the balance between these two functions is regulated by the level of expression. For instance, high expression of RPTPa may lead to activation of c-Src and low RPTPa levels may attenuate insulin receptor signalling. However, the role of RPTPa in c-Src or insulin receptor mediated signalling in vivo remains to be determined.
Immunohistochemistry
In conclusion, our data demonstrate that RPTPa is differentially expressed during embryogenesis.
RPTPa expression is not only regulated by transcription, but also by translation and/or post-translational mechanisms. Highest levels of RPTPa are expressed transiently in derivatives of the neural crest. The expression pattern of RPTPa during embryogenesis, together with our previous finding that RPTPa plays a decisive role in neuronal differentiation in vitro, suggests that RPTPa may function in postmigratory neural crest cell differentiation in vivo.
Experimental procedures
The generation of polyclonal anti-RPTPa antibody 5478 and affinity purification using a GST-fusion protein encompassing the complete cytoplasmic region of RPTPa has been described (den Hertog et al., 1994) . Immunohistochemistry was done according to standard protocols. Briefly, rehydrated paraffin sections were incubated in blocking buffer (50 mM Tris pH 7.5, 150 mM NaCl, 4% swine serum) for 1 h at room temperature, and subsequently with anti-RPTPa antibody 5478 (0.1 mg/ml, final concentration) in blocking buffer for 16 h at 4°C. Following extensive washing (3 X 20 min in TBS (50 mM Tris pH 7.5, 150 mM NaCl) with gentle shaking), the sections were incubated with biotinylated swine anti-rabbit antibody (DAK0 A/S, Glostrup, Denmark) in TBS containing 1% bovine serum albumin (BSA; Sigma, St. Louis, USA) for 1 h at room temperature. The slides were washed three times for 20 min in TBS with gentle shaking and enhancement was done using avidin and biotinylated horse radish peroxidase, exactly as described by the manufacturer (DAK0 A/S, Glostrup, Denmark). Finally, following three washes (10 min in TBS), the slides were developed using 3,3_diaminobenzidine tetrahydrochloride (DAB; 0.06%, final concentration; Sigma, St. Louis, USA) as a substrate (8-12 min), and stained with haematoxilin. As a control, the procedure described above was performed without anti-RPTPa antibodies, or with an antibody solution that had been incubated with excess glutathione-agarose linked GST-PTPa prior to use. The results of these control experiments were identical, in that no specific signal was detected.
Embryos
